Israel China Biotechnology (ICB) Ltd Long-term Investment Intensity
Israel China Biotechnology (ICB) Ltd long-term investment intensity. Israel China Biotechnology (ICB) Ltd (ICB) has a Long-term Investment Intensity of 44.9% as of June 2019. Long-term investments of ILA6.17 Million represent 44.9% of total assets of ILA13.74 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See ICB working capital ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Israel China Biotechnology (ICB) Ltd (2018–2018)
Long-term investment intensity of Israel China Biotechnology (ICB) Ltd from 2018 to 2018. This chart shows how Israel China Biotechnology (ICB) Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2018 to 2018. As of June 2019, the intensity stands at 44.9%, reflecting long-term investments of ILA6.17 Million against total assets of ILA13.74 Million ILA. See ICB defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Israel China Biotechnology (ICB) Ltd Long-term Investment Intensity by Year (2018–2018)
Israel China Biotechnology (ICB) Ltd long-term investment intensity by year from 2018 to 2018. The table below presents the year-by-year Long-term Investment Intensity for Israel China Biotechnology (ICB) Ltd from 2018 to 2018, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Israel China Biotechnology (ICB) Ltd's balance sheet.
| Year | LT Investment Intensity | LT Investments (ILA) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 34.3% | ILA3.39 Million | ILA9.88 Million | — |